Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

US FDA approves Roche's oral treatment for advanced breast cancer | Reuters

ReutersView source article

Part of story

FDA approves Roche's oral breast cancer pill Wilserdly

The FDA approved Roche's oral treatment for estrogen receptor-positive, HER2-negative advanced breast cancer, providing a new option for patients and a significant commercial boost for the Swiss drugmaker.

Nov 16, 2026·3 sourcesCancer & OncologyCancer and Cancer TreatmentDrug safetyTargeted cancer therapyCancer treatmentDrug Policy, Pricing & ApprovalClinical trialsPharmaceutical IndustryFDA drug approval
FDA approves Roche's oral breast cancer pill Wilserdly
00

Other sources for this story

STAT News

FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

Bloomberg

Roche Wins FDA Approval for Wilserdly Breast Cancer Pill in US